Search by Drug Name or NDC

    NDC 42291-0810-15 Tizanidine Hydrochloride 2 mg/1 Details

    Tizanidine Hydrochloride 2 mg/1

    Tizanidine Hydrochloride is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is TIZANIDINE HYDROCHLORIDE.

    Product Information

    NDC 42291-0810
    Product ID 42291-810_0e9ac170-4a35-d07c-e063-6394a90af8f4
    Associated GPIs 75100090100110
    GCN Sequence Number 058904
    GCN Sequence Number Description tizanidine HCl CAPSULE 2 MG ORAL
    HIC3 H6H
    HIC3 Description SKELETAL MUSCLE RELAXANTS
    GCN 24433
    HICL Sequence Number 011582
    HICL Sequence Number Description TIZANIDINE HCL
    Brand/Generic Generic
    Proprietary Name Tizanidine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tizanidine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, GELATIN COATED
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name TIZANIDINE HYDROCHLORIDE
    Labeler Name AvKARE
    Pharmaceutical Class Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078868
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0810-15 (42291081015)

    NDC Package Code 42291-810-15
    Billing NDC 42291081015
    Package 150 CAPSULE, GELATIN COATED in 1 BOTTLE (42291-810-15)
    Marketing Start Date 2014-06-20
    NDC Exclude Flag N
    Pricing Information N/A